Literature DB >> 15657777

Toxic clozapine serum levels during acute urinary tract infection: a case report.

Julia Jecel1, Tanja M Michel, Lise Gutknecht, Daniela Schmidt, Bruno Pfuhlmann, Burkhard E Jabs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15657777     DOI： 10.1007/s00228-004-0867-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

1.  Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism.

Authors:  O V Olesen; K Linnet
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

Review 2.  Metabolic drug interactions with new psychotropic agents.

Authors:  Edoardo Spina; Maria Gabriella Scordo; Concetta D'Arrigo
Journal:  Fundam Clin Pharmacol       Date:  2003-10       Impact factor: 2.748

3.  Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.

Authors:  K Raaska; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2000-11       Impact factor: 2.953

Review 4.  Interactions between the cytochrome P450 system and the second-generation antipsychotics.

Authors:  Trevor I Prior; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

5.  Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.

Authors:  U Jeppesen; L F Gram; K Vistisen; S Loft; H E Poulsen; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 6.  Hepatic drug metabolism and immunostimulation.

Authors:  K W Renton
Journal:  Toxicology       Date:  2000-01-17       Impact factor: 4.221

Review 7.  A review of the pharmacological and clinical profile of mirtazapine.

Authors:  S A Anttila; E V Leinonen
Journal:  CNS Drug Rev       Date:  2001

8.  The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

Authors:  K T Batty; T M Davis; K F Ilett; L J Dusci; S R Langton
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

9.  Metabolism and bioactivation of clozapine by human liver in vitro.

Authors:  M Pirmohamed; D Williams; S Madden; E Templeton; B K Park
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

10.  Bacterial pneumonia can increase serum concentration of clozapine.

Authors:  K Raaska; V Raitasuo; M Arstila; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2002-06-25       Impact factor: 2.953
View more
  10 in total

1.  Interaction of clozapine and ciprofloxacin: a case report.

Authors:  Rajvinder S Sambhi; Ramneesh Puri; Gaynor Jones
Journal:  Eur J Clin Pharmacol       Date:  2007-07-12       Impact factor: 2.953

2.  Infections and possible vaccine-drug interactions.

Authors:  Kari Raaska; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-08       Impact factor: 2.953

3.  Elevated clozapine plasma concentration secondary to a urinary tract infection: proposed mechanisms.

Authors:  Lik Hang N Lee; Randall F White; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

Review 4.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

5.  Burning pain secondary to clozapine use: a case report.

Authors:  Bradley Linton; Rachel Fu; Penny A MacDonald; Hooman Ganjavi
Journal:  BMC Psychiatry       Date:  2014-10-23       Impact factor: 3.630

6.  Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.

Authors:  Wai Hong Man; Ingeborg Wilting; Eibert R Heerdink; Gerard W K Hugenholtz; Tim Bognár; Maarten J Ten Berg; Wouter W van Solinge; Toine A C G Egberts; Erik M van Maarseveen
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

7.  Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.

Authors:  Camille Lenoir; Frédérique Rodieux; Jules A Desmeules; Victoria Rollason; Caroline F Samer
Journal:  Clin Pharmacokinet       Date:  2021-08-31       Impact factor: 6.447

Review 8.  Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.

Authors:  Siobhan Gee; Thomas Dixon; Mary Docherty; Sukhwinder S Shergill
Journal:  BMC Psychiatry       Date:  2015-08-12       Impact factor: 3.630

Review 9.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310

10.  Toxic clozapine level as first indication of severe, acute infection.

Authors:  Erica A K Davis; Tyler Hightower; Katherine Ann Cinnamon
Journal:  Ment Health Clin       Date:  2022-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.